Albert Farrugia: The Past, Present and Future of Blood Plasma Fractionation
Albert Farrugia Clinical Professor, UWA Medical School, Surgery, shared an inspiring post on LinkedIn:
“It is one of the honours of my life to be associated with the two great names and dear friends with whom this work was produced-John Curling and Leni von Bonsdorff .
I was keen on us developing this project after a long period of hearing the founders of this industry being denigrated by a number of ambitious adventurers who frequently refer to Cohn fractionation as “bucket chemistry ” with no innovative effort since its inception, in order to tout alternatives which have foundered before seeing the light of day.
In this paper, the industry’s history is reviewed, alternative technologies are assessed, and areas such as disruptive therapies and pathogen reduction are discussed.
The paper is available on Open Access and we welcome comments.
And, as I always say when I lecture on plasma fractionation:
‘First there was Cohn, and then there was Curling’.”
Read the full article here.
Article: The past, present and future of blood plasma fractionation
Authors: Albert Farrugia, John Curling, Leni von Bonsdorff
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Sep 4, 2026, 13:54Ahmad G. Alzahrani: A New Classification for Acute Pulmonary Embolism
-
Sep 4, 2026, 12:52James P. Crowley: MDS vs MPN – Understanding the Difference
-
Sep 4, 2026, 12:02Khalid Abdelsamea Mohamedahmed: Routine Blood Parameters in Pediatric Sickle Cell Anemia
-
Sep 4, 2026, 11:37Consuela A. Albright: The Power of Community Advocacy in Sickle Cell Disease
-
Sep 4, 2026, 11:18Aanika Roshni: When Blood, Biology, and Mechanics Intersect
-
Sep 4, 2026, 10:01Ifeanyichukwu Ifechidere: Making Coagulation Simpler and More Practical
-
Sep 4, 2026, 09:49Omid Khalafi: When the ‘Rules of Three’ Break – What Is Really Happening?
-
Sep 4, 2026, 09:27Hilly Paige: What ESC 2026 Taught Us About LDL-C Management
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk